Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Recall Procedures

Posted on By

SOP for Recall Procedures

Standard Operating Procedure for Recall Procedures

1) Purpose

The purpose of this SOP is to establish a procedure for initiating, implementing, and managing product recalls to ensure timely and effective removal of defective or potentially harmful products from the market.

2) Scope

This SOP applies to all personnel involved in the pharmaceutical manufacturing facility responsible for managing and executing product recalls.

3) Responsibilities

3.1 Quality Assurance (QA) Manager
– Oversee and coordinate the recall process.
– Ensure compliance with regulatory requirements and company policies.
3.2 Regulatory Affairs
– Assess regulatory impact and requirements for product recall.
– Communicate with regulatory authorities as necessary.
3.3 Production Manager
– Provide support for the recall process, including information on manufacturing and distribution.
3.4 Customer Service Representative
– Receive and document customer complaints related to recalled products.

See also  SOP for Environmental Monitoring in the Manufacturing Area

4) Procedure

4.1 Recall Initiation
4.1.1 Identify the need for a recall based on internal reports, customer complaints, or regulatory requests.
4.1.2 Notify the QA Manager and Regulatory Affairs of the recall initiation.
4.2 Recall Strategy Development
4.2.1 Formulate a recall strategy including scope, classification, and urgency of the recall.
4.2.2 Determine the recall depth (e.g., wholesale level, retail level) and geographic extent.
4.3 Notification and Communication
4.3.1 Prepare a recall notification

letter detailing the reason for recall, product description, and actions required by stakeholders.
4.3.2 Distribute recall notifications to affected parties, including distributors, retailers, and regulatory agencies.
4.4 Recall Execution
4.4.1 Monitor and track the progress of the recall, including retrieval of recalled products from the market.
4.4.2 Document all actions taken during the recall process, including product disposition and destruction.
4.5 Effectiveness Check
4.5.1 Evaluate the effectiveness of the recall by monitoring the return of recalled products.
4.5.2 Conduct a root cause analysis to prevent recurrence of similar issues.

See also  Injectables: SOP for Microbial Monitoring

5) Abbreviations, if any

– QA: Quality Assurance

6) Documents, if any

– Recall Notification Letters
– Recall Effectiveness Reports
– Recall Log

7) Reference, if any

– FDA Guidance for Industry: Product Recalls, Including Removals and Corrections
– ICH Q9 Quality Risk Management

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: SOP for Weight Variation Testing
Next Post: SOP for Stock Replenishment Planning

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version